Top Markets
Coin of the day
Ainos, Inc. Ainos, Inc.

Ainos, Inc.

AIMD
Rang in aandelen #32145
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Aandeelprijs
$1.49
Laatst gesynchroniseerd: 2026-08-17
Marktkapitalisatie
$10.94M
Verandering (1 dag)
4.58%
Verandering (1 jaar)
-55.67%
Land
US
Handel Ainos, Inc. (AIMD)

Categorie

P/B-ratio voor Ainos, Inc. (AIMD)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Ainos, Inc. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor Ainos, Inc. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH
- -
KR